Kovitz Investment Group Partners
PRCT icon

Kovitz Investment Group Partners’s Procept Biorobotics PRCT Stock Holding History

Kovitz Investment Group Partners’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$734K Hold
32,498
– – 0.02% 351
2026
Q1 		$813K Hold
32,498
– – 0.02% 345
2025
Q4 		$1.02M Sell
32,498
-38
-0.1% -$1.26K 0.02% 318
2025
Q3 		$1.16M Sell
32,536
-4,262
-12% -$195K ﹤0.01% 803
2025
Q2 		$2.12M Sell
36,798
-25
-0.1% -$1.41K 0.01% 620
2025
Q1 		$2.15M Buy
+36,823
New +$2.51M 0.01% 573

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Kovitz Investment Group Partners's PRCT Position: Q2 2026 in Review

Kovitz Investment Group Partners held its Procept Biorobotics (PRCT) position steady in Q2 2026 at 32,498 shares worth $734K. The position accounts for 0.02% of the portfolio, ranked #351.

Kovitz Investment Group Partners first reported a position in PRCT in Q1 2025 and has held it in 6 quarters since. The position peaked at $2.15M in Q1 2025. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Kovitz Investment Group Partners held 32,498 shares of Procept Biorobotics worth $734K as of Q2 2026.
  • Kovitz Investment Group Partners left its Procept Biorobotics share count unchanged in Q2 2026.
  • Procept Biorobotics made up 0.02% of Kovitz Investment Group Partners's portfolio in Q2 2026, its #351 holding.
  • Kovitz Investment Group Partners first reported a position in Procept Biorobotics in Q1 2025 and has held it in 6 quarters since.
  • Kovitz Investment Group Partners's Procept Biorobotics position peaked at $2.15M in Q1 2025.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Kovitz Investment Group Partners's 13F filing for Q2 2026, filed 12 Aug 2026.